October 2026, Asset Allocation
Hi, I'm Matt Bance, and welcome to our July 2026 asset allocation update. I'll briefly outline how our portfolios are positioned and highlight some of the key changes we've made over the past month.
Let's start with the overall shape of the portfolio.
We remain overweight equities and have recently increased that position. However, we've continued to trim our overweight to credit as spreads have become increasingly compressed. We also remain underweight duration, primarily in the US.
Overall, our positioning reflects what we see as a supportive economic backdrop, with inflation remaining the more important risk than slowing growth.
We believe the most acute phase of the Middle Eastern conflict has now passed and expect oil flows to continue normalising, albeit with periodic flare-ups, at least through the US mid-term elections.
We think markets are likely to look through the political headlines and remain focused on oil flows and lower energy prices, which have helped moderate inflation expectations.
After a softer patch last year, the US labour market has shown a clear improvement. Measures of business activity, such as purchasing managers' indices, have also continued to improve despite ongoing uncertainty.
Second, we've been adding to European equities. From an economic perspective, Europe is one of the largest beneficiaries of improved energy flows and lower oil prices. Investor positioning had become decisively bearish, leaving scope for investor flows to improve as the outlook strengthens.
Third, we've increased our overweight to emerging market equities.
Emerging markets remain one of our preferred ways of gaining exposure to the structural AI investment cycle, particularly through supply-chain bottlenecks. This investment theme has come a long way since we first initiated it, with Taiwan and South Korea now overtaking China as the largest country weights within the benchmark, reflecting their central role in the AI supply chain.
For now, we believe the competitive pressure on the largest US technology companies to continue investing in AI remains firmly in place. We therefore expect capital spending—and the debt issuance helping to fund it—to remain supportive over the coming year.
Thanks very much for joining us, and we look forward to updating you again next month.
* For pairwise decisions in style, market capitalisation (size) and currencies, positioning within boxes represents positioning in the first‑mentioned asset class relative to the second asset class.
T. Rowe Price Europe and UK Regional Investment Committees inform the global asset allocation views. This material is not intended to be investment advice or a recommendation to take any particular investment action.
As of 30 September 2026.
I’m Michael Walsh, and welcome to our October monthly asset allocation update. This month we’ve modestly increased portfolio risk – but we’re being selective about where we take it.
We’ve increased our conviction in US large-cap growth and emerging markets, reduced our overweight to UK equities, and become more constructive on high-quality bonds.
Let me take you through what’s driving those changes.
Within equities, we increased our overweight to US large-cap growth. Earnings growth remains strong, supported by continued investment in and adoption of artificial intelligence. At the same time, the recent derating has made valuations more attractive. Expectations around AI remain high, however, and there is still uncertainty around the returns companies will ultimately generate from this investment.
We also increased our overweight to emerging-market equities. Relative valuations remain compelling and the earnings backdrop is supportive, while continued investment in AI infrastructure provides an additional tailwind. Against that, we remain mindful of increasing technology and country concentration, as well as sensitivity to the global semiconductor cycle.
We partially funded these increases by reducing our overweight to UK equities. We still see attractive valuations and healthy earnings. But fiscal concerns, persistent inflation and policy uncertainty ahead of the Budget have made us somewhat more cautious.
Finally, we removed our cash overweight and added to fixed-income, although we remain underweight overall. Recent increases in high-quality bond yields have made duration more attractive, both from a return perspective and for its potential role as a portfolio anchor.
Looking at the UK in particular, weaker growth and softer labour-market conditions also suggest that inflationary pressures could moderate. We are now neutral on gilts as a result. Given our more positive view on duration, and increases in portfolio risk elsewhere, we also closed our overweight position in global high yield.
So, overall, we remain moderately pro-risk, but selective: favouring areas where we see attractive fundamentals, valuations and diversification potential.
Thank you very much.
Sep 2026
Asset Allocation
Investment Insight
Aug 2026
Asset Allocation
Investment Insight
IMPORTANT INFORMATION
This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, nor is it intended to serve as the primary basis for an investment decision. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested.
The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction.
Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources' accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date noted on the material and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price.
The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request.
It is not intended for distribution to retail investors in any jurisdiction.